All Type of News


MFDS to raise the vaccine self-sufficiency rate to 80% by 2020

The Ministry of Food and Drug Safety announced on the 25th that they selected 7 more products as subject of the support for ‘global vaccine commercialization’ with systematic consulting services for development to com...

"It is necessary to legislate pharmacy opening standards"

In a statement on the 28th, the Gyeongsangnam-do Pharmaceutical Association suggested an opinion that it is necessary to legislate standards of opening pharmacies which meets public interests. They criticized that no...

Hanall Biopharma & Daewoong Pharmaceutical announce U.S. Phase II clinical trial of new dry eye therapy

On the 29th, Hanall Biopharma and Daewoong Pharmaceutical announced their U.S. Phase II clinical trial(a.k.a. Topline) result of the dry eye treatment biosimilar HL036 that they are jointly developing. The Phase II cl...

Maviret, Eloctate & Alprolix newly registered for health insurance benefits from 1 June

Chronic hepatitis C treatment Maviret and hemophilia treatments Eloctate & Alprolix will newly be added to the list of health insurance benefits from 1 June. Sovaldi Tab and Harvoni Tab will voluntarily drop their pr...

Harnovi kills hepatitis C only in 8 weeks

Gilead Sciences’ hepatitis C treatment Harvoni(generic name: ledipasvir/sofosbuvir) have shown excellent efficacy only with a 8-week therapy, not 12 weeks. Gilead Sciences Korea held a press conference to celebrate e...

“Pharmaceutical field with high contributions to job creation”

At the end of the last year, the number of employees was 64,200 people, increased by 3.9% compared to the same quarter of the year before, which proved the pharmaceutical business is a great business to create new job...

Chong Kun Dang signs co-sales agreement of dementia therapy ‘Aricept’ with Eisai Korea

Chong Kun Dang(CEO Young-Joo Kim) signed a co-sales agreement of dementia therapies ‘Aricept’ and ‘Aricept Evess’ with Eisai Korea at the Chong Kun Dang’s headquarters located in Chungjeongno, Seoul on the 28th. Unde...

MFDS suspends use of products containing 'benzocaine' on children less than 24 months old

The Ministry of Health and Welfare announced on the 28th that the ministry would send a safety letter containing articles about prohibiting using medicinal drugs with benzocaine, local anesthetic, on children and infa...

‘Personal Health Doctor Program for the Disabled’ started from 30 May

In order to manage health of the disabled, the ‘Personal Health Doctor Program for the Disabled’ will start a demo project. The Ministry of Health and Welfare(Minister Neung-Hoo Park) will start a demo project for th...

How listed pharmas did with sales?

In the 1st quarter of this year, both KOSPI and KOSDAQ listed pharmaceutical companies had an increase of approximately 6% in sales compared to the same quarter of the last year. Yakup Shinmoon(www.yakup.com) analyze...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.